Skip to main content
Clinical Trials/NCT04962373
NCT04962373
Completed
Not Applicable

Brief Admission by Self-referral for Adolescents Who Self-harm, at Risk for Suicide. A Qualitative Study to Optimise and Standardise the Intervention

Region Skane1 site in 1 country59 target enrollmentSeptember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Self-Harm, Deliberate
Sponsor
Region Skane
Enrollment
59
Locations
1
Primary Endpoint
Areas where Brief Admission have the most prominent perceived effects in adolescents
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

There is still no consensus on how to manage suicidal behavior in youth with recurrent self-harm at times when the risk for suicide is imminent (1). Brief Admission (BA) has evolved as a promising crisis intervention for adults with self-harm (2). The characteristics of BA is different from other types of admission, being focused on prevention through increased autonomy and self-care, based on structured and voluntary brief self-referrals to hospital (3). As a result of a randomized controlled trial, BA is since January 2019, continuously offered to adults with self-harm at risk for suicide in Skåne (4). Parallel to this clinical trial, the method has been adapted to work in a psychiatric setting for adolescents. At present 24 adolescents have access to the method in Skåne. Clinical experiences from staff are promising, however, the lived experiences have not been collected in a standardized way.

The aim of the present study is to gather information on how BA in its present, standardized form works for adolescents, their loved ones and staff working at the ward providing BA. This will be done through semi-structured interviews with:

  1. Adolescents using BA and their loved ones
  2. Staff working at the ward providing BA. Data will be analyzed with qualitative analysis (5, 6). The ultimate aim is to use these results to optimize the current standardized version of BA for adolescents in order to test in a randomized clinical trial.
Registry
clinicaltrials.gov
Start Date
September 1, 2020
End Date
June 30, 2025
Last Updated
8 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sofie Westling

Principal Investigator

Region Skane

Eligibility Criteria

Inclusion Criteria

  • Adolescents with an active BA contract
  • At least 13 years of age.
  • Able to consent to study participation through written and oral information.
  • Consent from caregivers
  • Given consent to participate

Exclusion Criteria

  • Below the age of
  • Inclusion Criteria:
  • Parents to adolescents with an active BA contract
  • At least 18 years of age.
  • Able to consent to study participation through written and oral information.
  • Given consent to participate
  • Exclusion Criteria:
  • Inclusion Criteria:
  • Staff working with adolescents with an active BA contract
  • At least 18 years of age.

Outcomes

Primary Outcomes

Areas where Brief Admission have the most prominent perceived effects in adolescents

Time Frame: 60mins

Qualitative data from interviews

Potential adaptations of the method to better fit adolescents

Time Frame: 60mins

Qualitative data from interviews

Perceived effective components of Brief Admission for adolescents

Time Frame: 60mins

Qualitative data from interviews

Study Sites (1)

Loading locations...

Similar Trials